Literature DB >> 27843199

Corrigendum to "Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential".

Masayo Aoki1, Hiroaki Aoki1, Rajesh Ramanathan2, Nitai C Hait3, Kazuaki Takabe4.   

Abstract

[This corrects the article DOI: 10.1155/2016/8606878.].

Entities:  

Year:  2016        PMID： 27843199      PMCID： PMC5098090          DOI： 10.1155/2016/2856829

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN： 0962-9351            Impact factor:   4.711


In the article titled “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential” [1], there was an error in the “FTY720 and Lymphopenia” section, where the sentence “p-FTY720 causes continued cAMP signaling that is not dependent on S1P1R redistribution and induces functional antagonism of Ca2+ signaling after transient stimulation” should be corrected to “p-FTY720 causes continued cAMP signaling that is not dependent on S1PR1 redistribution and induces functional antagonism of Ca2+ signaling after transient stimulation.”
  1 in total

Review 1.  Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential.

Authors:  Masayo Aoki; Hiroaki Aoki; Rajesh Ramanathan; Nitai C Hait; Kazuaki Takabe
Journal:  Mediators Inflamm       Date:  2016-02-07       Impact factor: 4.711
  1 in total
  5 in total

1.  Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.

Authors:  Eriko Katsuta; Li Yan; Masayuki Nagahashi; Ali Raza; Jamie L Sturgill; Debra E Lyon; Omar M Rashid; Nitai C Hait; Kazuaki Takabe
Journal:  J Surg Res       Date:  2017-06-29       Impact factor: 2.192

Review 2.  Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer.

Authors:  Junko Tsuchida; Masayuki Nagahashi; Kazuaki Takabe; Toshifumi Wakai
Journal:  Mediators Inflamm       Date:  2017-08-22       Impact factor: 4.711

3.  Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy.

Authors:  Rajesh Ramanathan; Ali Raza; Jamie Sturgill; Debra Lyon; Jessica Young; Nitai C Hait; Kazuaki Takabe
Journal:  Mediators Inflamm       Date:  2017-09-24       Impact factor: 4.711

4.  S1P1 Regulates M1/M2 Polarization toward Brain Injury after Transient Focal Cerebral Ischemia.

Authors:  Bhakta Prasad Gaire; Young Joo Bae; Ji Woong Choi
Journal:  Biomol Ther (Seoul)       Date:  2019-06-11       Impact factor: 4.634

5.  Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.

Authors:  Limei Zhong; Linling Xie; Zhiyong Yang; Lijuan Li; Shaohua Song; Donglin Cao; Yufeng Liu
Journal:  BMC Cancer       Date:  2020-08-15       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.